Jochen Pfirstinger
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
-
- Chemokine receptors and signaling
Papers in
-
- Platelet Disorders and Treatments 2
-
- Palliative Care and End-of-Life Issues 4
- Co-authors
- Matthias Mack (6 shared papers)Detlef Schlöndorff (5 shared papers)Hilke Brühl (4 shared papers)Amanda E. I. Proudfoot (1 shared paper)Hans‐Joachim Anders (1 shared paper)Josef Cihak (1 shared paper)M. Stangassinger (1 shared paper)Bruno Luckow (1 shared paper)
- Journals
- The Journal of Immunology (3 papers)Oncology (2 papers)European Journal of Immunology (2 papers)BMJ Open (1 paper)Supportive Care in Cancer (1 paper)
- Partner nations
- GermanyCzechiaSwitzerland
In The Last Decade
Jochen Pfirstinger
16 papers receiving 626 citations
Peers
Comparison fields: 5 of 85
- Immunology 309
- Oncology 170
- Neurology 44
- Nephrology 31
- Immunology and Allergy 25
Countries citing papers authored by Jochen Pfirstinger
This map shows the geographic impact of Jochen Pfirstinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Pfirstinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Pfirstinger more than expected).
Fields of papers citing papers by Jochen Pfirstinger
This network shows the impact of papers produced by Jochen Pfirstinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Pfirstinger. The network helps show where Jochen Pfirstinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Pfirstinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 391 | |
| 2 | 2002 | 87 | |
| 3 | 2009 | 30 | |
| 4 | 2017 | 22 | |
| 5 | 2002 | 22 | |
| 6 | Effective treatment of steroid refractory adult-onset Still's disease with anakinra. | 2008 | 20 |
| 7 | 2014 | 16 | |
| 8 | 2005 | 11 | |
| 9 | 2016 | 10 | |
| 10 | 2017 | 7 | |
| 11 | 2013 | 7 | |
| 12 | 2010 | 6 | |
| 13 | 2011 | 6 | |
| 14 | 2002 | 3 | |
| 15 | 2010 | 1 | |
| 16 | 2003 | 1 |
About Jochen Pfirstinger
Jochen Pfirstinger is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Immunology, Cell Biology and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 640 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (4 papers), T-cell and B-cell Immunology (3 papers), Advanced Fiber Optic Sensors (2 papers), Chemokine receptors and signaling (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Platelet Disorders and Treatments (2 papers), Mast cells and histamine (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology (309 citations), Oncology (170 citations), Neurology (44 citations), Nephrology (31 citations) and Immunology and Allergy (25 citations). Jochen Pfirstinger has collaborated with scholars based in Germany, Czechia and Switzerland. Frequent co-authors include Matthias Mack, Detlef Schlöndorff, Hilke Brühl, Amanda E. I. Proudfoot, Hans‐Joachim Anders, Josef Cihak, M. Stangassinger, Bruno Luckow, Jiřı́ Plachý and Michael Frink. Their work appears in journals such as The Journal of Immunology, Oncology, European Journal of Immunology, BMJ Open and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.